Author

Jacques Gaudreault

Observed names: J GAUDREAULT, J. Gaudreault, JACQUES GAUDREAULT

Institution: Allgemeine Gewerbeschule Basel

Observed institutions: F. Hoffmann-La Roche AG, Fox Chase Cancer Center, City Of Hope National Medical Center, Kaiser Permanente, University of California, Los Angeles, University of California, San Francisco, Pfizer (United States), Genentech, Vanderbilt University, Baylor University Medical Center, Mary Crowley Cancer Research Center, Roche (France), City of Hope, Allgemeine Gewerbeschule Basel, Indiana University Indianapolis, Vanderbilt-Ingram Cancer Center, Université de Montréal

ORCID: 0009-0000-6391-131X

Observed ORCID: 0009-0000-6391-131X

OpenAlex ID: A5079213166

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

2004 · David H. Johnson, Louis Fehrenbacher, et al. · Journal of Clinical Oncology · 1,949

Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration

2005 · Jacques Gaudreault, David Fei, et al. · Investigative Ophthalmology & Visual Science · 505

Clinical pharmacokinetics of bevacizumab in patients with solid tumors

2008 · Jian-Feng Lu, Rene Bruno, et al. · Cancer Chemotherapy and Pharmacology · 367

Phase Ib Trial of Intravenous Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor in Combination With Chemotherapy in Patients With Advanced Cancer: Pharmacologic and Long-Term Safety Data

2001 · K. Margolin, M. S. Gordon, et al. · Journal of Clinical Oncology · 362

Pharmacokinetics and Retinal Distribution of Ranibizumab, a Humanized Antibody Fragment Directed Against Vegf-a, Following Intravitreal Administration in Rabbits

2007 · JACQUES GAUDREAULT, DAVID FEI, et al. · Retina · 185

Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo

2007 · John Lowe, James Araujo, et al. · Experimental Eye Research · 172

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

2023 · David H. Johnson, Louis Fehrenbacher, et al. · Journal of Clinical Oncology · 122

A Placebo‐Controlled Evaluation of Single, Escalating Doses of CL 284,846, a Non‐Benzodiazepine Hypnotic

1994 · Bernard Beer, John R. Ieni, et al. · The Journal of Clinical Pharmacology · 82

First-in-man Study With Inclacumab, a Human Monoclonal Antibody Against P-selectin

2015 · Christophe Schmitt, Markus Abt, et al. · Journal of Cardiovascular Pharmacology · 59

PDF

Design, Construction, and In Vitro Analyses of Multivalent Antibodies

2003 · Kathy Miller, Gloria Meng, et al. · The Journal of Immunology · 54

Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab – preclinical and clinical studies

2013 · Dorothee Kling, Corinne Stucki, et al. · Thrombosis Research · 51

Preclinical Pharmacology and Safety of ESBA1008, a Single-chain Antibody Fragment, Investigated as Potential Treatment for Age Related Macular Degeneration

2012 · Jacques Gaudreault, Tea Gunde, et al. · Investigative Ophthalmology & Visual Science · 47

Update on AVOREN trial in metastatic renal cell carcinoma (mRCC): Efficacy and safety in subgroups of patients (pts) and pharmacokinetic (PK) analysis

2008 · B. J. Escudier, A. Ravaud, et al. · Journal of Clinical Oncology · 43

Complexation of VEGF with Bevacizumab Decreases VEGF Clearance in Rats

2002 · Vanessa Hsei, Geralyn G. DeGuzman, et al. · Pharmaceutical Research · 37

Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis

2021 · Paul Brogan, Rae S. M. Yeung, et al. · Arthritis & Rheumatology · 30

Population Pharmacokinetics of Terfenadine

1996 · Richard L. Lalonde, Denis Lessard, et al. · Pharmaceutical Research · 28

Truncated Area Under the Curve as a Measure of Relative Extent of Bioavailability: Evaluation Using Experimental Data and Monte Carlo Simulations

1998 · Jacques Gaudreault, Diane Potvin, et al. · Pharmaceutical Research · 26

Mixed-effects modeling of the pharmacodynamic response to the calcimimetic agent R–568

1999 · R LALONDE, J GAUDREAULT, et al. · Clinical Pharmacology & Therapeutics · 20

Ocular Pharmacokinetics of Faricimab Following Intravitreal Administration in Patients With Retinal Disease

2024 · Cheikh Diack, Leonid Gibiansky, et al. · Translational Vision Science & Technology · 17

Concomitant Administration of Bevacizumab, Irinotecan, 5-Fluorouracil, and Leucovorin: Nonclinical Safety and Pharmacokinetics

2005 · Jacques Gaudreault, Vanessa Shiu, et al. · International Journal of Toxicology · 15

Pharmacokinetics and Anticonvulsant Effect of a New Hypnotic, CL 284,846, in Rats

1995 · Jacques Gaudreault, France Varin, et al. · Pharmaceutical Research · 12

Clinical pharmacokinetics of bevacizumab following every 2- or every 3-week dosing

2004 · J. Gaudreault, R. Bruno, et al. · Journal of Clinical Oncology · 11

Anticonvulsant Pharmacodynamics and Disposition of Triazolam in Rats††These results were presented, in part, at the Seventh Annual Meeting of the American Association of Pharmaceutical Scientists, San Antonio, TX, November 1992.

1996 · Jacques Gaudreault, France Varin, et al. · Journal of Pharmaceutical Sciences · 11

Preclinical Characterization of XB002, an Anti–Tissue Factor Antibody–Drug Conjugate for the Treatment of Solid Tumors

2024 · Seema Kantak, Raffaella Faggioni, et al. · Molecular Cancer Therapeutics · 9

PDF

Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis

2022 · Candice Jamois, Leonid Gibiansky, et al. · Clinical and Translational Science · 8

PDF

Works count: 50

Citation count: 4,255

H-index: 18

I10-index: 23